Axalta Exceeds Q1 Guidance with Strong Cash Flow; Provides Q2 and Full-Year 2026 Outlook
summarizeSummary
Axalta Coating Systems announced first-quarter 2026 financial results, exceeding its guidance for key metrics and reporting record cash flow, while also providing its outlook for the second quarter and full year.
check_boxKey Events
-
Exceeded Q1 Guidance
Axalta surpassed its guidance for first-quarter net sales, Adjusted EBITDA ($259 million), and Adjusted Diluted EPS ($0.56).
-
Record Cash Flow Generation
The company reported record first-quarter cash provided by operating activities of $68 million and record free cash flow of $21 million, both significantly up year-over-year.
-
Provided Q2 and Full-Year 2026 Outlook
Axalta projects Q2 2026 Adjusted Diluted EPS of approximately $0.65 and full-year 2026 Adjusted Diluted EPS between $2.55 and $2.70, with full-year free cash flow expected to be over $500 million.
-
Progress on AkzoNobel Merger
Management confirmed that workstreams associated with the proposed merger of equals with AkzoNobel are progressing as planned and are on track with the stated timeline.
auto_awesomeAnalysis
Axalta Coating Systems reported first-quarter results that surpassed its own guidance for net sales, Adjusted EBITDA, and Adjusted Diluted EPS, demonstrating operational strength despite a dynamic macroeconomic environment. The company also achieved record first-quarter cash flow from operations and free cash flow, indicating improved liquidity and financial health. While some year-over-year metrics saw declines, the beat on expectations and robust cash generation are positive signals. The updated guidance for Q2 and full-year 2026 provides investors with a clearer forward-looking picture, and the company confirmed it is on track with the proposed merger of equals with AkzoNobel, a significant strategic event previously disclosed.
At the time of this filing, AXTA was trading at $28.21 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $24.94 to $35.72. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.